human blood coagulation factor ii

The drug is used for the treatment of bleeding and its prevention before surgery in cases of acquired clotting factor deficiency (e.g., due to the intake of vitamin K antagonists or their overdose), as well as in congenital clotting factor deficiency if specialized products are unavailable.

Form: powder and solvent for injection solution

ATC: B02BD01

Manufacturer: Takeda Manufacturing Austria AG (batch release; manufacturing, in-process control, batch quality control and stability testing of the medicinal product; labelling, primary and secondary packaging of the medicinal product and diluent; batch quality control and stability testing (Sterility and Bacterial Endotoxins))

The drug is used for the treatment of bleeding and the prevention of bleeding before surgery. It is applied in cases of acquired clotting factor deficiency (e.g., due to the intake of vitamin K antagonists) or in cases of congenital factor deficiency if no specialized drug is available.

Form: powder for solution for infusion

ATC: B02BD01

Manufacturer: Kedrion S.p.A.

The drug is used for the treatment of bleeding and its prevention before surgery. This applies to cases where there is a deficiency of blood clotting factors in the body, for example, due to the intake of certain medications (vitamin K antagonists) or due to congenital deficiency of these factors.

Form: powder and solvent for infusion solution

ATC: B02BD01

Manufacturer: Kedrion S.p.A.